Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 27/8/20011 min de lectura
Clinical Studies of Safety and Effectiveness of Orphan Products; Availability of Grants; Request for Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing changes to its Orphan Products Development (OPD) grant program for fiscal year (FY) 2002. This announcement supersedes the previous announcement of this program, which was published in the Federal Register of August 8, 2000.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →